Skip to main content

Volume 16 Supplement 1

1st Joint ANIRCEF-SISC Congress

  • Oral presentation
  • Open access
  • Published:

O056. Migraine as presenting symptom of SLC20A2gene mutations


Idiopathic basal ganglia calcifications (IBGC), also known as Fahr's disease, are neurological diseases characterized by symmetric calcium deposits in basal ganglia and other brain regions. Clinically, IBGC patients show high phenotypic heterogeneity, both in the clinical manifestations and neuroradiological findings. Recently, PDGFRB, PDGFB, XPR1 and SLC20A2 have been identified as causative genes for IBGC[1].

The aim of this study was to report on two Italian patients with idiopathic basal ganglia calcifications associated with novel mutations in the SLC20A2 gene who both presented with episodic migraine.

Materials and methods

Two 48-year-old unrelated women presented to the Headache Center, Department of Neuroscience “Rita Levi Montalcini”, University of Torino, with a long-lasting history of headache. The reported symptoms fulfilled ICHD-III beta version criteria for episodic migraine without aura (code 1.1). Computed tomography scans showed in both cases severe calcifications at the bilateral globus pallidus, caudate nuclei, putamen, and dentate nuclei. On the basis of neuroradiological findings, SLC20A2 gene was sequenced.


A novel missense mutation Gly63Asp (exon 1) and a frameshift mutation p.Val507Glufs*2 (c.1520_1521delTG, exon 8) in the isoform 1 of the SLC20A2 gene were identified. In silico analysis showed that the first substitution was predicted to have a damaging role. For the frameshift mutation, the genetic variant was found to change an aminoacid and insert a stop codon, likely leading to a degradation of the mutated messenger RNA.

Discussion and conclusions

The clinical manifestations in patients with IBGC range widely from neurological and psychiatric symptoms to asymptomatic status[2]. We suggest that migraine should be considered when evaluating patients with IBGC and first-degree relatives, in particular in young age, when other neurological symptoms are absent. The identification of new genetic variants further enlarge the spectrum of mutations in SLC20A2, helping to better elucidate the worldwide distribution and the different clinical features.

Written informed consent to publication was obtained from the patient(s).


  1. Wang C, Li Y, Shi L, Ren J, et al: Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012, 44: 254-256. 10.1038/ng.1077.

    Article  CAS  PubMed  Google Scholar 

  2. Nicolas G, Pottier C, Charbonnier C, et al: Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain. 2013, 136: 3395-3407. 10.1093/brain/awt255.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Elisa Rubino.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rubino, E., Giorgio, E., Rainero, I. et al. O056. Migraine as presenting symptom of SLC20A2gene mutations. J Headache Pain 16 (Suppl 1), A121 (2015).

Download citation

  • Published:

  • DOI: